Eric Triau
Impact in
- Psychiatry and Mental health top 5%
- Dementia and Cognitive Impairment Research
- Physiology top 5%
- Alzheimer's disease research and treatments
Papers in
-
- Alzheimer's disease research and treatments 4
-
- S100 Proteins and Annexins 3
- Co-authors
- Koen Van Laere (6 shared papers)Natalie Nelissen (1 shared paper)Éric Salmon (2 shared papers)Ian Law (4 shared papers)Lennart Minthon (2 shared papers)Alex Kørner (1 shared paper)Gill Farrar (1 shared paper)Adrian Ivanoiu (4 shared papers)
- Journals
- Alzheimer s & Dementia (2 papers)Molecular Psychiatry (1 paper)Neurology (1 paper)The Lancet Neurology (1 paper)Annals of Neurology (1 paper)
- Partner nations
- BelgiumSwedenUnited Kingdom
In The Last Decade
Eric Triau
10 papers receiving 766 citations
Eric Triau's Hit Papers
Peers
Comparison fields: 5 of 78
- Psychiatry and Mental health 323
- Physiology 349
- Radiology, Nuclear Medicine and Imaging 144
- Cognitive Neuroscience 125
- Neurology 50
Countries citing papers authored by Eric Triau
This map shows the geographic impact of Eric Triau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Triau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Triau more than expected).
Fields of papers citing papers by Eric Triau
This network shows the impact of papers produced by Eric Triau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Triau. The network helps show where Eric Triau may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Triau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial Hit paper breakdown → | 2010 | 532 |
| 2 | 2008 | 119 | |
| 3 | 2020 | 71 | |
| 4 | 2022 | 34 | |
| 5 | 1994 | 15 | |
| 6 | 2009 | 4 | |
| 7 | Image Acquisition System to Monitor Discomfort in Demented Elderly Patients | 2008 | 3 |
| 8 | 2009 | 2 | |
| 9 | Image Acquisition System to Monitor Discomfort in Demented Elderly Patients | 2007 | 2 |
| 10 | 2009 | 1 | |
| 11 | Primary Outcome Analysis of the Multicentre Phase II Trial of 18F-Flutemetamol, a Pittsburgh Compound B Derivative for In Vivo Beta Amyloid Imaging | 2010 | 0 |
About Eric Triau
Eric Triau is a scholar working on Physiology, Molecular Biology, Cognitive Neuroscience, Radiology, Nuclear Medicine and Imaging and Critical Care and Intensive Care Medicine, having authored 11 papers that have together received 783 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (4 papers), S100 Proteins and Annexins (3 papers), Functional Brain Connectivity Studies (2 papers), Cell Adhesion Molecules Research (1 paper), Protease and Inhibitor Mechanisms (1 paper), Stroke Rehabilitation and Recovery (1 paper), Intensive Care Unit Cognitive Disorders (1 paper) and Dementia and Cognitive Impairment Research (1 paper). The work is most often cited by research in Psychiatry and Mental health (323 citations), Physiology (349 citations), Radiology, Nuclear Medicine and Imaging (144 citations), Cognitive Neuroscience (125 citations) and Neurology (50 citations). Eric Triau has collaborated with scholars based in Belgium, Sweden and United Kingdom. Frequent co-authors include Koen Van Laere, Natalie Nelissen, Éric Salmon, Ian Law, Lennart Minthon, Alex Kørner, Gill Farrar, Adrian Ivanoiu, Steen Gregers Hasselbalch and Gaëtan Garraux. Their work appears in journals such as Alzheimer s & Dementia, Molecular Psychiatry, Neurology, The Lancet Neurology and Annals of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.